美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Gastar Exploration

0.0561

0.0000

成交量：- -

成交额：- -

市值：1,228.22万

市盈率：-0.13

高：0.0561

开：0.0561

低：0.0561

收：0.0561

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

广生堂(300436.SZ)：GST-HG131联合GST-HG141针对乙肝经治患者的临床试验申请获得受理

广生堂(300436.SZ)：乙肝治疗创新药GST-HG131联合GST-HG141的II期临床研究获得优化审评审批试点项目确认书

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GST"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GST\",,,,,undefined,":{"symbol":"GST","market":"US","secType":"STK","nameCN":"Gastar Exploration","latestPrice":0.0561,"timestamp":1536249826821,"preClose":0.0561,"halted":4,"volume":0,"delay":0,"floatShares":69350000,"shares":218933504,"eps":-0.421675,"marketStatus":"退市","change":0,"latestTime":"05-13 13:55:30 EDT","open":0.0561,"high":0.0561,"low":0.0561,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.421675,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747166400000},"marketStatusCode":2,"symbolChange":{"newSymbol":"GSTC","executeDate":"2018-09-07"},"adr":0,"adrRate":0,"listingDate":1136437200000,"exchange":"AMEX","adjPreClose":0.0561,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GST\",,,,,undefined,":{"symbol":"GST","floatShares":69350000,"roa":"--","roe":"--","lyrEps":-0.313395,"shares":218933504,"dividePrice":0,"high":0.0561,"amplitude":0,"preClose":0.0561,"low":0.0561,"week52Low":0.0561,"pbRate":"-0.13","week52High":1.39,"institutionHeld":0.3263,"latestPrice":0.0561,"eps":-0.421675,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.421675,"open":0.0561},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GST\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GST\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520540785","title":"广生堂(300436.SZ)：GST-HG131联合GST-HG141针对乙肝经治患者的临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2520540785","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520540785?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 20:08","pubTimestamp":1742213297,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广生堂(300436.SZ)发布公告，公司创新药控股子公司福建广生中霖生物科技有限公司(简称“广生中霖”)于近日收到国家药品监督管理局下发的关于乙肝治疗创新药GST-HG131联合GST-HG141的临床试验申请《受理通知书》，拟针对核苷(酸)类似物NUC经治乙肝患者，挑战临床治愈乙肝。前述II期临床研究已于日前被纳入优化创新药临床试验审评审批试点项目，将有效缩短本次临床试验申请的审评审批周期。本次GST-HG131联合GST-HG141的II期临床试验申请获得受理，尚需进一步获得批准后才可开展临床研究，能否获得批准开展临床存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1262987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GST","03347","300436","BK1576","BK0239","BK1141","BK1583"],"gpt_icon":0},{"id":"2518221805","title":"广生堂(300436.SZ)：乙肝治疗创新药GST-HG131联合GST-HG141的II期临床研究获得优化审评审批试点项目确认书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221805","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518221805?lang=zh_cn&edition=fundamental","pubTime":"2025-03-10 21:05","pubTimestamp":1741611951,"startTime":"0","endTime":"0","summary":"2025年3月10日，福建广生堂药业股份有限公司创新药控股子公司福建广生中霖生物科技有限公司收到北京市药品监督管理局下发的《优化创新药临床试验审评审批试点项目确认书》，同意GST-HG131联合GST-HG141的II期临床研究纳入试点项目，将有效缩短临床审评审批周期。2025年1月，GST-HG131已按照II期临床方案要求完成了计划例数全部的患者入组。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10210548635518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK1574","159992","06978","BK1161","300436","GST"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GST\",params:#limit:5,,,undefined,":[{"date":"2018-09-07","symbol":"GST","newSymbol":"GSTC","type":"symbolChange","dateTimestamp":1536292800000},{"market":"US","date":"2018-08-09","symbol":"GST","fiscalQuarterEnding":"2018/06","expectedEps":-0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2018-05-10","symbol":"GST","fiscalQuarterEnding":"2018/03","expectedEps":-0.04,"name":null,"time":"盘后","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2018-03-15","symbol":"GST","fiscalQuarterEnding":"2017/12","expectedEps":-0.03,"name":null,"time":"盘后","type":"earning","dateTimestamp":1521086400000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2017-11-08","symbol":"GST","fiscalQuarterEnding":"2017/09","expectedEps":-0.04,"name":null,"time":"盘后","type":"earning","dateTimestamp":1510117200000,"reportTimeType":"post","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GST\",market:\"US\",delay:false,,,undefined,":{}}}